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Abstract 
Aim: Type-2 diabetes is a risk factor for coronary artery disease (CAD), however, a number of 
studies have shown that patients are asymptomatic for CAD. The presence of CAD in 
asymptomatic patients with type-2 diabetes were evaluated to determine its impact on 
management decision and prognosis.  
Methods: Seventy five patients underwent SPECT myocardial perfusion imaging for detection 
of suspected CAD. We used 17 segment model for perfusion and function analysis. Multislice 
computed tomography was performed in 45 patients to assess coronary calcium score (CAC). 
Complete laboratory analyses with lipid values and standard risk factors were analyzed. Forward 
logistic regression analysis was used to assess predictive parameters for myocardial ischemia 
during the follow up period of 20±4 months.  
Results and Conclusion: Silent myocardial ischemia and subclinical CAD can be detected in a 
significant proportion of asymptomatic patients with type-2 diabetes. Diabetic patients with normal 
myocardial perfusion imaging had an excellent 2 year prognosis with optimal medical therapy and 
intensive risk factor control. In comparison, an abnormal myocardial perfusion imaging led to an 
increased risk of cardiovascular events. Myocardial perfusion imaging and CAC are valuable tools 
for risk-stratification and optimal treatment decision in this asymptomatic diabetic cohort of 
Macedonian patients. . 
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Introduction 
 
The risk of type-2 diabetes increases with age, especially over the age of 50. Coronary artery 
disease (CAD) is the leading cause in morbidity, mortality and cost of management of patients 
with type-2 diabetes. Acute myocardial infarction or sudden cardiac deaths are often the first 
clinical presentations in asymptomatic diabetic patients due to the insufficient screening for CAD 
[1]. These events are linked to increased morbidity, mortality and socioeconomic burden. The 
dilemma on the cost effectiveness of screening for myocardial ischemia in asymptomatic 
diabetic patients in relation to the optimal therapeutic approach is still ongoing. There is 
controversy whether noninvasive imaging such as, myocardial perfusion imaging (MPI) 
improves type-2 diabetic patient management and prognosis. Proposed strategies that may 
favourably affect CAD risk and outcomes in high risk asymptomatic population include 
identifying patients with subclinical disease at high risk of future cardiac events. Current risk 
score models (SCORE, FRAMINGHAM, PROCAM) show inferiority for individual risk 
stratification and ability to predict the presence of ischemia [2-4]. MPI with gated single photon 
emission computed tomography (SPECT) is a non-invasive imaging scan of the heart commonly 
used to diagnose and evaluate prognosis of patients with known or suspected CAD [1,2]. There 
is increased interest in the use of coronary artery calcium (CAC) imaging to assess early 
subclinical atherosclerosis and total atherosclerosis burden, in patients with intermediate 
cardiovascular risk [3-5]. CAC is also a proven prognostic parameter in diabetic patients [6, 7]. 
Whilst simple categorical risk factors, such as, hypertension, hyperlipidemia, obesity, smoking, 
age etc, cannot effectively discriminate which asymptomatic high risk type-2 diabetic patients 
will or will not have ischemia on stress testing [5]. it is still possible however, that risk factor 
burden may predict risk of cardiovascular events in individual patients. Herein, we assessed the 
prognostic value of coronary atherosclerosis and myocardial ischemia in asymptomatic diabetic 
patients of a Macedonian cohort. We also determined how noninvasive imaging could influence 
treatment strategies in these patients.  
 
Methods 
        
Study design and data source 
 
A prospective cohort study was designed and 75 consecutive asymptomatic patients with type-2 
diabetes (41 male, 34 female; age range 63 ± 9 years), without previously known or established 
CAD were included in the study. All patients completed the World Health Organization Rose 
Angina Questionnaire for confirmation of the asymptomatic status. Screening for myocardial 
ischemia was performed using MPI SPECT imaging in the nuclear cardiology laboratory at our 
clinic in the period of October 2012 - November 2013. Prospective follow-up was complete in all 
75 patients (100 %) with a median period of 20 months (16 - 24months). CAC scores were 
performed and data evaluated using Agatston units. 2D transthoracic echocardiography was 
used for assessment of systolic and diastolic left ventricular function with GE VIVID7 echo 
machine. We have screened 93 diabetic patients, from which 75 with preserved left ventricular 
systolic function and left ventricular ejection fraction (LVEF>50%), assessed by 
echocardiography Simpson’s rule enrolled the study and were included in the final patient 
cohort. Distribution of study subjects are presented in Flow Chart 1. 
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All patients underwent a physical examination and included blood pressure measurements, 
weight, height, waist circumference, body mass index (BMI) and risk factors analysis. Full blood 
examination with high density lipoprotein (HDL), low density lipoprotein (LDL), non-HDL and 
triglyceride levels, fasting glucose levels, % glycated hemoglobin (HbA1c), and blood creatinine 
levels were performed within a maximum of 2 weeks prior to MPI. Medical history was evaluated 
and corrected according to target risk factor goals based on latest European society of 
cardiology (ESC) recommendations for cardiovascular prevention and hypertension treatment 
for all patients. Clinical and laboratory characteristics are shown in (Table 1). The following 
inclusion criteria were used: asymptomatic patients with type-2 diabetes, normal rest left 
ventricular function with EF > 50 %. Exclusion criteria were: typical stable angina pectoris, 
previously known or established CAD (history of myocardial infarction, acute coronary 
syndromes, previous percutaneous intervention or coronary artery bypass surgery), LVEF < 50 
% at rest, severe valvular disease, atrial fibrillation, left bundle branch block, presence of pace 
maker, severe chronic pulmonary disease. The study was approved by the Human Ethics 
Committee of the Medical Faculty, University St. Ciril and Methodius in Skopje, Macedonia. All 
patients signed an informed consent. 
 
Definition of study variables 
 
Risk factor definitions were made according to the most recent ESC guidelines on hypertension, 
hyperlipidemias and cardiovascular prevention: arterial hypertension (systolic blood pressure 
(SBP) > 140 bpm or diastolic BP > 90 bpm), dyslipidaemia (LDL > 1.8 mmol/l;  high-density 
lipoprotein < 1.1 and 1.0 mmol/l for females and males respectively and triglycerides > 1.7 
mmol/l), family history of myorcardial infarction or sudden cardiac death in an immediate male 
relative < 55 years or female < 65 years, smoker (current smoker or those who quit in the past 6 
months). BMI ≥ 30 kg/m² was used to define to define obese patients. Type-2 diabetes mellitus 
was defined as established disease in patients treated with oral anti-diabetic medication or 
insulin following initial treatment with oral anti-diabetic therapy. Newly diagnosed diabetes was 
defined as having either one of the following criteria, base on the ESC guidelines on pre-
diabetes and diabetes: fasting glucose of 7.0 mmol/L or non-fasting glucose 11.0 mmol/L in 2 
separate samples, HbA1c > 6.5 % or pathologic oral glucose tolerance test in patients with 
fasting glucose over 6.5 without previously known  or treated diabetes. Electrocardiography 
(ECG) abnormalities at rest were defined as the presence of ST-T abnormalities, Q-waves, T-
wave inversion.  
        
Myocardial perfusion SPECT imaging (MPI) 
 
MPI SPECT imaging was performed using one day rest stress protocol with radiotracer 
technetium (Tc-99m) sestamibi, using 15 mCi for the rest and 25 mCi for the stress study. We 
used single head gamma camera Siemens e-cam, with commercially available quantitative 
gated and perfusion SPECT software package (4DM-SPECT). Patients were instructed to 
refrain from caffeine-containing beverages for at least 12 hours (h), nitrates for 24 h, and beta-
blockers for 48 h before the study. All patients underwent pharmacological stressing with 
dipyridamole. We used the 17-segment model for quantitative Bull’s eye analysis of regional 
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myocardial perfusion and function. Myocardial perfusion was assessed by 5 point score system 
(0-normal radiotracer uptake; 1- mild, 2-moderate; 3- severe hypo perfusion; 4- absent uptake). 
Semi quantitative analysis of regional perfusion at rest and stress was performed using summed 
stress score (SSS), summed rest score (SRS) and summed differential score (SDS), aimed to 
assess the presence and extend of myocardial ischemia. Scan abnormalities were defined as 
follow: SSS < 4 normal perfusion; 4-8 mild; 9-13 moderate; > 13 severely abnormal scan. SDS 
< 6 mild (< 10 % of left ventricle (LV)); SDS 7-10 moderate (10-15 % of LV); SDS > 10 severe 
ischemia (> 15 % of LV). Fixed defects were defined as SRS > 4. Any perfusion abnormality 
was defined as SDS > 4 and/or SRS > 4. LV volumes, left ventricular ejection fraction (LVEF) at 
rest and stress, presence of transit ischemic LV dilation (TID), visualisation of right ventricle and 
lung uptake were also analyzed. Regional wall motion analysis was assessed by a 6 point 
scoring system at rest and stress (0 - normal wall motion, 1 - mild, 2 - moderate; 3 - sereve 
hypokinesia, 4 - akinesia, 5 - dyskinesia) using wall motion score index.  
       
Results considered normal were those that showed a homogenous distribution of the radiotracer 
throughout the LV myocardium at the stress and resting images and with normal systolic 
movement and thickening. The fixed perfusion defects, present in both images and with a 
segmental contractile deficit and systolic thickening were interpreted as fibrosis. Transient 
perfusion defects, present at the stress phase and absent at the resting phase, with normal 
range of movement and thickening, were considered to be ischemia. When the recovery of 
these defects was only partial, with a contractile deficit, it configured the simultaneous existence 
of fibrosis and ischemia. 
 
Coronary Calcium Score (CAC) Imaging 
 
For CAC imaging, a non-enhanced, prospectively ECG-gated scan was obtained by use of a 
128-slice CT scanner (Siemens Somatom Definition 128 AC+, single source). The estimated 
effective radiation dose for this protocol was bellow 1 mSv. Image reconstruction was performed 
at 55 % of the R-R interval with prospective gating usage. The total calcium burden in the 
coronary arteries was measured according to the scoring algorithm of Agatston. On the basis of 
the total Calcium score expressed in Agatston Units (AU), patients were placed into 5 
categories, as previously reported [8]: CAC 0- no evidence of atherosclerosis; CA 1-10AU 
(minimal or insignificant CAC), 11–100 (mild CAC), 101–400 (moderate CAC), 401–1.000 
(severe CAC). Total CAC score and CAC score in each coronary artery was evaluated.  
 
Coronary angiography 
 
All patients with at least moderate myocardial ischemia (SDS >7) underwent coronary 
angiography. Invasive coronary angiograms were evaluated by consensus of 2 interventional 
cardiologists who were unaware of the SPECT and CAC imaging results. Segments were 
classified as normal, as having nonobstructive disease or as having significant stenosis (50 % 
stenosis). Presence, localization, severity of coronary stenosis and number of vessels involved 
were analyzed using Syntax score. Percutaneous coronary intervention with stenting or 
coronary artery bypass surgery was performed according to the latest myocardial ESC 
revascularization guidelines, based on invasive cardiologist’s team decision. 
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Medical therapy and life style advice  
 
Medical therapy was reviewed in detail and all patients underwent an optimal medical treatment 
with life style and risk factor control advice and targets based on the latest ESC guidelines for 
cardiovascular prevention and management of stable CAD. 
 
Follow up  
 
Patients were prospectively followed for a median of 20 ± 4 months. The following were 
considered as cardiovascular events: sudden cardiac death; acute coronary syndrome (ACS) 
with or without ST-segment elevation; myocardial revascularization with percutaneous coronary 
intervention (PCI) or coronary artery bypass surgery (CABG) and cerebrovascular events 
(cerebrovascular insult-CVI). The follow-up of the sample was carried out by six months clinical 
visits until the end of the follow up period, or in earlier periods in case of change in clinical 
symptoms or clinical event. 
 
Statistical analysis 
 
Statistical analysis was performed with the use of the SPSS statistical package (version 18.0).  
Categorical variables were compared using chi-square test and continuous variables using 
unpaired Student t test. Normality of variables distribution was performed. Categorical values 
were expressed in percentages, continued as mean value ± SD. Linear regression analysis was 
used to determine whether there was a correlation between the CAC score and perfusion 
abnormalities on SPECT.  Multivariate forward stepwise logistic regression analysis was built in 
order to identify factors associated independently with the presence of silent myocardial 
ischemia and prognosis. The analysis includes age, gender, hypertension, hyperlipidemia, 
smoking, obesity, diabetes duration, MPS perfusion scores, ECG ST segment depression 
during pharmacological stress and CAC. The criterion for entrance into the model was a 
univariate probability value of p<0.05 and p>0.10 for removal from the model. P<0.05 was 
considered to be statistically significant for all statistical tests.  Cumulative event-free survival 
rates as a function over time were obtained using the Kaplan-Meier method. Cardiac event-free 
survival curves were compared using the log-rank test. To identify the association between 
clinical and imaging variables and outcomes, Cox regression analysis was used.  
 
Results 
 
Follow-up was attained in all 75 patients. Study demographics consisted of 41 male (55 %) and 
34 female patients (45 %), with mean age of 65 and 69 years respectively, as shown in (Table 
1). The prevalence of metabolic risk factors, blood examination and medical therapy are 
presented in Table 1. All patients had on average 2 risk factors. The risk factors for the 
cardiovascular disease were distributed as follows: 76 % of systemic arterial hypertension; 51.4 
% of dyslipidemia; 14 % of cigarette-smoking, 12 % with obesity and 44 % of family history for 
coronary history. Average duration of diabetes was 8 ± 3 years. 11 patients (15 %) used insulin 
therapy.  
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Myocardial SPECT findings     
 
The stress phase was carried out through pharmacological stress with dipyridamole in all 
patients. Total of 1275 segments were analyzed. All patients showed normal rest left ventricular 
function with EF > 55.0 % assessed by Gated SPECT. Fifty six patients (74.6 %) had normal 
MPI results. The scintigraphy results were abnormal in 19 patients (25.3 %). Stress inducible 
ischemia was found in 18 patients (24.0 %). Ischemia plus fibrosis with fixed perfusion defects 
were found in 3 patients and fixed defects only in 1 patient, which could indicate the presence of 
previous silent myocardial infarction. Mild ischemia was found in 6 patients - summed difference 
score (SDS) < 4, moderate ischemia (SDS 7-10) in 7 and severe ischemia (SDS > 10) in 5 
patients (Figures 1 and 2). Average wall motion index (WMI) in patients with ischemia was 1.25. 
Patients with severe ischemia had a drop of LVEF during stress study by > 5.0 % and transit 
ischemic dilation (TID). There was a correlation with diabetes and stress ECG changes with the 
presence of myocardial ischemia (r=0.54 and r=0.58 respectively). When the scintigraphy 
results were analyzed we noted that the patients with abnormal perfusion were significantly 
older male population (p=0.01), when compared to the group with normal perfusion. 
 
Coronary calcium Score findings 
 
CAC score was assessed in total 135 coronary arteries. Subclinical atherosclerosis was present 
in 35 patients from 45 (77.7%) who had CAC score evaluated. Ten patients had CAC score 0 
AU; 4 patients had CAC score 1-10 AU; 15 patients had mild CAC score (11-99 AU); 7 patients 
had moderate CAC (100-399 AU) and 9 patients had severe CAC (401-1000 AU). No patients 
had extensive CAC > 1000 AU. Calcium was present in the in the left anterior descending 
coronary artery (LAD) in 17 patients, in the left circumflex artery (LCX) in 6 patients, and right 
coronary artery (RCA) in 12 patients, respectively. The average calcium score in the LAD (289 ± 
72) was significantly higher than those in the LCX (115 ± 56) and in the RCA (192 ± 68). 
Patients with moderate and severe ischemia had CAC score 667 ± 112AU. Patients with normal 
MPI scan had an average CAC score of 25 ± 18AU. 
             
The subclinical atherosclerosis group were older, predominantly males and 15 were smokers. 
Independent predictors of subclinical atherosclerosis were age (≥ 65 years) [odds ratio (OR): 
1.068, 95.0 % confidence interval (CI): 1.05-1.92, p=0.026], diabetes (OR: 1.89, 95 % CI: 1.1-
2.76, p=0.052) and smoking (OR: 1.73, 95 % CI: 1.2-2.21, p=0.041) in multivariate forward 
logistic regression analysis. 
 
Relationship Between CAC Imaging and Gated SPECT 
 
The relationship between the prevalence and severity of myocardial perfusion abnormalities and 
the extent of CAC is shown in Figure 3. Nine patients with normal SPECT results showed 
atherosclerosis with mild CAC score (11-99 AU). Contrary, 8 patients with moderate CAC and 6 
patients with severe CAC had abnormal perfusion. The mean CAC score was significantly 
higher in subjects with at least moderate ischemia than in those who had normal SPECT results 
(667 ± 112 vs. 149 ± 45; p<0.001).  
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Predictors of  Myocardial ischemia 
 
Stepwise forward logistic regression analysis for prediction of stress-induced ischemia in the 
model that included CAC, showed OR 2.4 (95.0 % CI 1.7−3.6) for stress-induced ECG changes, 
OR 2.8 for CAC > 400 (95.0 % CI 1.9-3.2) and OR 3.9 for presence of type-2 diabetes over 10 
years  (95.0 % CI 2.3−6.6) is shown in Table 2. The second stepwise forward logistic regression 
model which did not include CAC, showed OR 2.1 (95 % CI 1.3−3.4) for male gender, OR 2.4 
for hyperlipidemia (95.0 % CI 1.7-3.8) and OR 3.7 for presence of type-2 diabetes over 10 years  
(95.0 % CI 2.2−5.7) is shown in Table 3 and 4. Relationship between percentage and severity of 
myocardial perfusion abnormalities and extent of CAC is presented in Figure 2 .     
 
Cardiovascular events and frequency of revascularization procedures during  
follow-up 
 
There were no cardiac deaths, myocardial infarctions or heart failure during the follow up period. 
All patients with moderate severe ischemia were referred for coronary angiography (n=12). 
From 12 patients with at least moderate ischemia, 8 patients had significant CAD and 
underwent PCI revascularization (66.6 %) (Table 4, 5). Two patients had PCI to RCA, 3 patients 
had PCI to LAD and 1 patient had PCI to LAD and LCx. Other 4 patients had angiographycally 
non significant CAD and received an advice for intensive medical treatment. Patients with mild 
ischemia (SDS <7) and normal MPI findings were put on intensive medical therapy and life style 
modification. The average CAC score in these patients was 590 ± 145. Three patients were 
hospitalized due to non-stable angina, two with previous severe ischemia and one with normal 
MPI study. Patients with normal MPI had a low revascularization rate of 1.3 % during the follow 
up period, and no other cardiovascular events in the follow up period. Revascularization rate in 
the studied cohort was 2.1 % during the follow up period of 20 ± 4 months. Univariate analysis 
of variables that influence future events,presented with following predictive values: 
Hyperlipidemia (score 2.275, p=0.031), DMT2 duration over 10 years (score = 3.125, p=0.021), 
CAC>400 (score = 2.117, p=0.018) and SDS>7 (score = 4.173, p=0.0012). Results of univariate 
analysis are summarized in Table 6. SDS>7 (OR: 2.0371, p=0.001) and diabetes duration over 
10 years (OR: 1.9136, p=0.002), stepped into the multivariate model, showed independent 
predictive values (Table 7). Kaplan Maier curves (Figure 3) showed significant difference 
between event free survival and degree of myocardial ischemia (Long rank p=0.000, Chi-square 
62.319). 
 
Discussion        
 
This study showed diabetes duration, stress ECG ST segment depression and coronary calcium 
score >400AU as predictors of at least moderate myocardial ischemia in high risk asymptomatic 
patients in logistic regression model which includes CAC. Male gender, hyperlipidemia and 
diabetes duration over 10 years were predictors of silent ischemia in the second model which 
excluded CAC. The aim of screening for silent CAD in high risk patients is to detect disease in 
the early stage, taking into consideration that up to 60.0 % of male and 42.0 % of female 
patients, the first initial presentation of CAD is acute myocardial infarction and 40.0 % with 
sudden cardiac death [1,2]. There has been a long debate and conflicting opinions concerning 
the optimal screening approach in asymptomatic patients with high cardiovascular risk. The 
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scientific data gives arguments that, atherosclerosis and myocardial ischemia imaging in 
selected asymptomatic moderate and high risk adults to be used, although prognostic 
implications of this approach are not clear [3]. The prevalence of silent ischemia ranges 
between 22-63.0 % in diabetic patients. We noted that 18 patients (24.0 %) had stress inducible 
ischemia and 12 of them had at least moderate ischemia. Our results showed high negative 
predictive value of the normal myocardial scintigraphy scan and good intermediate prognosis in 
diabetic patients. Four patients in our study (5.3 %) had fixed perfusion defects alone and in 
combination with ischemia, which indicate 5.3% had previous silent myocardial infarctions. This 
finding is correlation with the previous studies data, which reports the incidence of silent IM of 
5% (18.20). The study reports the revascularization rate of 2.1 % for 20 ± 4 months. Eight 
patients with at least moderate ischemia (66.6 %) underwent PCI revascularization. Three 
patients from our study were hospitalized for ACS (4.0 %), two with previous incomplete 
revascularization and severe ischemia and one patient with normal study. All patients with 
normal MPI study (74.6 %) had good prognosis with no hard events, and revascularization rate 
of 1.3 % during the follow up period of 20 ± 4 months. Multivariate Cox regression analysis 
showed SDS > 7 and diabetes duration over 10 years as independent predictor of CV events 
(OR 2.0371, p<0.001 and OR 1.9136, p<0.002), after adjustment for hyperlipidemia and CAC > 
400. 
 
The concept of diabetes as CAD equivalent was introduced following the Finnish population-
based study [3]. Based on several epidemiological studies, diabetic patients are considered as 
high risk population [5]. However, it has been argued that CAD risk equivalence in diabetes is 
also influenced by additional risk factors, target organ damage and the presence of vascular 
disease. The use of vascular imaging may improve the individual risk assessment in diabetic 
patients.  Acampa and co-workers found significant risk reclassification after MPS use in 
diabetic patients with suspected or known CAD [6]. The value of noninvasive imaging of diabetic 
vascular disease has been confirmed in several studies and also in our previous study [7,9].  
  
From a management and prognostic perspective, the important question is whether we are able 
to improve the overall state for diabetic patients? Will vascular damage and ischemia 
assessment improve long term prognosis? Recommended risk stratification models have 
evident inferiorities, which do not include many additional risk factors such as, diabetes, family 
history and obesity. These models do not predict the presence of myocardial ischemia or 
atherosclerosis which has prognostic information. From the data we have thus far, patients with 
at least moderate myocardial ischemia with 10 % or more of the left ventricle involved, are 
suitable candidates for invasive treatment, although the long term benefits of this approach are 
still not confirmed in prospectively randomized ischemia based treatment studies. In fact, there 
was no significance in the BARI 2D trial in relation to survival [10]. Furthermore, there was no 
significance between major cardiovascular events in patients treated with medical therapy or 
revascularization [10].  
 
The occurrence of ischemia as detected by SPECT myocardial scintigraphy in asymptomatic 
type-2 diabetic patients, demonstrated, that myocardial ischemia was highly prevalent in type-2 
diabetic patients (34.0 %) vs 17.0 % in control subjects [11]. The findings of reversible perfusion 
defects were only significantly associated with the presence of type-2 diabetes. The proof of 
CAD presence suggests the necessity to increase pharmacological therapy and risk factor 
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control. In addition, the presence of atherosclerosis may also improve patient compliance and 
acceptance of life-style changes. 
  
A number of studies involving CAD screening in type-2 diabetic patients did not show any 
correlation amongst the number of associated risk factors to inducible ischemia as assessed 
SPECT imaging [12-13]. However, these studies did not evaluate, severity, duration, and, 
treatment modalities of risk factors, in patients with long term type-2 diabetes. Furthermore, 
differences between the studies may also be a reflection of the differences between diabetes 
management, glucose and risk factor control and diabetes complications in different countries. 
European guidelines on cardiovascular prevention and treatment of stable CAD as well as 
American guidelines on screening for CAD in asymptomatic adults indicates that imaging of 
atherosclerosis and functional imaging of CAD have a place and can be used in this population 
[4,14]. An important clinical question however, is whether ischemia should be screened in order 
to make a treatment decision. From a clinical point of view, the management dilemma should 
not be between medical versus invasive treatment, but rather which patient and when should 
invasive treatment be offered. In fact, the large ongoing ISCHEMIA Trial may answer many of 
these dilemma’s and may provide the best initial treatment strategies for patients with stable 
CAD who have at least moderate ischemia on non-invasive imaging tests. 
 
In a meta-analysis study which evaluated type-2 diabetic patients who had normal MPI SPECT 
readings, it was noted that the rate of cardiac death or non fatal myocardial infarction per annum 
was significantly lower (0.6%) in non type-2 diabetic patients compared to type-2 diabetic 
patients [16]. The extent and severity of myocardial ischemia is a strong risk predictor of 
coronary events [16-19]. In fact, the annual rates for cardiac events in type-2 diabetic patients 
varied, with mild (1-2 %), moderate (3-4 %) and severe (7.0 %) perfusion defects [18]. The only 
large prospective study for detection of asymptomatic ischemia in non-selected type-2 diabetic 
patients with no prior CAD noted that 22% of patients presented with an abnormal MPI SPECT, 
and severe perfusion abnormalities were noted in 6.0 % of the patients [13]. Of interest, males, 
duration of diabetes and the presence of cardiac autonomic dysfunction strongly correlated to 
ischemia [13]. Herein, we noted abnormal MPS results in 25.3 % of the patients. Stress 
inducible ischemia was found in 18 patients (24.0 %), from which 12 patients had moderate and 
severe ischemia. We had confirmed the impact of myocardial ischemia detected by MPI on 
management decision in high risk asymptomatic patient in our previous study [15]. The study 
showed that type-2 diabetic patients without a history of CAD and normal MPI have a relatively 
good 2 year prognosis. We found 4 false positive results of myocardial perfusion imaging (4 of 
12 had myocardial perfusion abnormalities with normal coronary angiography). These findings 
could be explained that microvascular dysfunction is often present in diabetic patients with 
multiple risk factors. This process could lead to heterogeneous myocardial perfusion and 
myocardial ischemia, without the presence of significant CAD. The repetitive episodes of 
myocardial ischemia due to microvascular dysfunction in larger myocardial regions, could result 
in fibrosis, myocardial remodeling and development of diabetic cardiomyopathy. 
  
A large observational study demonstrates that coronary calcium can be used as a prognostic 
marker even in patients with type-2 diabetes. Type-2 diabetic patients with zero CAC demonstrated 
an excellent 5-year survival rate but was not significantly different to control subjects (98.8 % and 
99.4 % respectively, p<0.05) [8]. However several studies evaluating CAC in diabetic patients 
opponent the established opinion that DM type 2 is per se CAD equivalent. CV risk in diabetic 
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patients actually is quite heterogenic and not all diabetic patients had the same risk. CAC 0 put the 
patient in lower risk group with expected good intermediate prognosis. The determinant factors to 
use coronary artery calcium as a screening method of atherosclerosis should be based on 
individual clinical approach and patient risk assessment. This test might be performed if the results 
are expected to influence the management decision. In fact, high risk patients can be re-stratified 
into a lower risk category by presence of zero calcium score, which also selects patients with good 
long term prognosis [20, 21, 22]. In our study patients with moderate and severe ischemia had 
Agatston CAC score 667 ± 112. The presence of atherosclerosis is not necessarily the entity that 
leads to perfusion abnormalities. However, scintigraphic findings do not exclude the presence of 
obstructive CAD, but only indicates the absence of hemodinamicaly significant CAD. In a study 
using MPI, the prevalence of silent ischemia was 18% in individuals with a CAC score of 100–400, 
with abnormal MPI findings in 45 % of patients with a CAC score over 400 [23]. Our results are in 
correlation with other studies underlying no absolute linearity of increasing CAC values and 
myocardial ischemia findings, since these methods assess different aspects of CAD. We found that 
diabetic patients with normal myocardial perfusion imaging had good 2 year prognosis with optimal 
medical therapy. The risk for cardiovascular events increased as a function of perfusion scan 
abnormality. Larger prospective clinical trials with longer follow up period are necessary to 
demonstrate the prognostic influence and ability of risk reclassification with SPECT imaging in 
asymptomatic diabetic patients. 
 
Study limitations 
 
The small sample we have evaluated could represent a limitation of our study. Nevertheless, 
our results could aid in improving our understanding of the relationship between functional and 
anatomic aspects of CAD in asymptomatic type-2 diabetic patients and their prognostic 
implications. CAC was performed in only 45 patients due to technical reasons. 
 
Conclusion 
 
Presence of silent myocardial ischemia in asymptomatic type-2 diabetic patients is high, and 
increases with diabetes duration. CAC imaging may be useful in identifying patients with 
extensive atherosclerosis without stress-induced ischemia, who may be referred for risk factor 
modification and aggressive medical treatment. CAC over 400 Agatston units, male gender and 
diabetes duration over 10 years predicted the risk of silent ischemia in our study. Multivariate 
regression analysis showed SDS > 7 as MPI variable and diabetes duration over 10 years as 
predictors of CV events. These results indicate that myocardial perfusion imaging and CAC are 
valuable tools for risk-stratification and optimal treatment decision in this asymptomatic diabetic 
cohort of Macedonian patients. 
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Figure Legends 
 
Flow chart 1. Distribution of study subjects 
 
Figure 1. Severity of ischemia in the studied population (n=18)    
 
Figure 2. Relationship between percentage and severity of myocardial perfusion abnormalities 
and extent of coronary artery calcification      
 
Figure 3. Kaplan-Meier survival curves as a function of myocardial perfusion scintigraphy 
results and severity of myocardial ischemia 
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Table 1   
Clinical characteristics of the study population 
____________________________________________________        
Variables    Patients n = 75       
____________________________________________________        
Age     65 ± 9 years 
Gender    41 males, 34 females 
Hypertension    57.0 (76 %) 
Hyperlipidemia   39.0 (52 %) 
Obesity    12.0 (16 %) 
Peripheral artery disease  7.0 (9.3 %) 
HbA1c     7.4 ± 1.2 % 
Ejection fraction   61.0 ± 6.0 % 
Family history of CAD  33.0 (44.0 %) 
Active smoker    10.0 (13.3 %) 
HDL      0.9 ± 0.4 mmol/l 
LDL     3.2 ± 0.4 mmol/l 
Triglycerides    2.3 ± 0.6 mmol/l 
Mean risk factors per patient  2.0 ± 1.0  
ACE/ARBs    75.0 (100 %) 
C-ant     54.0 (72.0 %) 
Diuretic    48.0 (64.0 %) 
Beta-blocker    21.0 (28.0 %) 
Statins     75.0 (100 %) 
Aspirin     75.0 (100 %) 
Insulin     11.0 (15.0 %) 
Oral hypoglycemic agent  56.0 (75.0 %) 
____________________________________________________        
Abbreviations: HDL-high density cholesterol; LDL-low density 
cholesterol; CAD-coronary artery disease; hs-CRP- high sensitivity CRP 
 
 
 
 
Table  2 
Model 1. Multivariate Stepwise logistic regression analysis for predictors of stress induced 
ischemia (model includes CAC) 
 
    B S.E. Wald  df Sign OR       95%   
DM >10 year  1.855  0.221  5.110  1  0.000  3.352 2.748  6.287  
ECG SSTD    1.061  0.568  6.989  1  0.000  2.176  1.984  3.277  
CAC 1.487  1.578  7.413  1  0.003  2.367  1.916  3.198  
Abbreviations: DM, type-2 diabetes mellitus; CAC, coronary calcium score; ECG SSTD, electrocardiogram  
stress ST depression; OD, odds ratio; CI, confidence interval; S.E, standard error 
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Table 3 
Model 2. Multivariate Stepwise logistic regression analysis for predictors of stress induced 
ischemia (model excludes CAC) 
 
    B S.E. Wald df Sign OR 95% CI  
Male gender 1.942  0.931  5.259 1  0.000  2.145 1.398  3.471  
  HLP 1.048 0.429 5.841  1  0.000  2.476  1.781  4.163  
DM >10y 1.637  1.579 7.415  1  0.003  3.732  2.296  5.731 
Abbreviations: HLP- hyperlipidemia; DM, type-2 diabetes mellitus; CAC, coronary calcium score; OD, 
odds ratio; CI, confidence interval; S.E, standard error 
 
 
 
 
Table 4 
Frequency of revascularization procedures and acute coronary syndromes during follow-up period 
Patients (n=75) 
 Revascularized                
< 30 days             
Revascularized                                      
> 30 days    
 ACS rate/2 years 
Myocardial ischemia n=18    7 1 3 (4.0%) 
Normal MPS study n=57    0 1 0 
CAC 1-10 0 0 0 
CAC 11-99 1 0 0 
CAC 100-399 6 1 0 
CAC 400-999 1 0 2 
Abbreviations: ACS, acute coronary syndrome; CAC, coronary calcium score; MPS, myocardial perfusion 
imaging 
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Table 5  
Cox regression analysis of predictors of cardiac  events 
 
 Score df Significance 
Age 0.149 1 0.789 
HTA 0.047 1 0.816 
HLP 2.275 1 0.031 
Obesity 0.172 1 0.599 
Smoking 0.001 1 0.861 
DM>10 3.125 1 0.021 
DM5-10 1.892 1 0.176 
CAC>400 1117 1 0.018 
CAC100-
399 
1.925 1 0.151 
SDS>7 4.173 1 0.012 
SDS<7 0.168 1 0.733 
Method: Forward Stepwise (Conditional LR).  
Abbreviations: HTA, Hypertension; HLP, hiper-lipidemia; 
DM, diabetes mellitus; CAC, calcium score; SDS, 
summed differential score 
 
 
 
 
 
Table 6. 
 Multivariate analysis for predictors of cardiac events 
 
    B S.E. Wald df Sign  R Exp (B) 
SDS>7   5.6271  3.924  5.2693 1  0.001  2.0371 24189.3681  
DM >10y -5.5982  2.151 4.2539 1  0.002  1,9136 0.0163 
Abbreviations: DM, type, 2 diabetes mellitus; SDS, summed stress score;  
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Flow chart 1. 
 
 
 
 
 
 
 
 
 
 
Figure 1.  
 
 
 
 
75 asymptomatic  
type 2 diabetic patients 
All underwent SPECT Myocardial 
perfusion and echocardiography 
Clinical follow up for all patients 
45 patients underwent CAC 
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Figure 2.  
 
 
              
 
 
 
Figure 3.  
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